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Background: Tuberculosis is one of the major infectious diseases in Taiwan. It has an especially high prevalence in
diabetes patients, in whom it is usually asymptomatic and are more likely to result in drug-resistant tuberculosis.
The aim of the study was to aggressively screen high risk diabetic elderly, identify the prevalence of tuberculosis
and its determinants.
Methods: Type 2 diabetes patients aged over 65 years were enrolled. They received chest X-rays, blood tests and the
questionnaires to assess their medical history and symptoms. Suspicious cases were referred to the pulmonary or
infectious disease outpatient clinics. Pulmonary tuberculosis was confirmed by sputum culture. Variables between
groups were analyzed by Student t test, Chi-square test or Fisher’s exact test. Risk factors were assessed using univariate
logistic regression and multiple logistic regression.
Results: A total of 3,087 patients participated this screening program and 7 patients screened positive for pulmonary
tuberculosis. Another 5 patients were being under treatment when participating screening program. The prevalence
rate was 3.89 per thousand people. The patients with male gender, smoking, liver cirrhosis or subjective body weight
loss were associated with an increased risk of tuberculosis significantly. Subjective body weight loss (OR: 6.635 [95% CI:
2.096-21.007]), liver cirrhosis (OR: 10.307 [95% CI: 2.108-50.395]) and history of smoking (OR: 3.981 [95% CI: 1.246-12.718])
are independent risk factors. Among all 73 patients with active tuberculosis or tuberculosis history, they tended to be
male, lower body mass index (BMI), more smoking history, more alcohol consumption, more family history of
tuberculosis, higher low density lipoprotein (LDL), and less hypertension. However, there was no significant difference
in the glycated hemoglobin (HbA1c) levels between the tuberculosis group and non-tuberculosis group.
Conclusions: Active screening program is helpful in detecting pulmonary tuberculosis in elderly diabetes patients.
Subjective body weight loss, smoking and liver cirrhosis are independent risk factors.
Keywords: Pulmonary tuberculosis, Diabetes mellitus, Risk factorsBackground
Tuberculosis (TB) and diabetes mellitus (DM) are both
the major global health problems. According to the
World Health Organization (WHO), there were an esti-
mated 8.7 million incident cases of TB and 1.4 million
deaths from TB in 2011 [1]. On the other hand, the* Correspondence: pengys66@gmail.com
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more than 371 million people all over the world had
DM and 471 billion USD were spent treating diabetes in
2012 [2]. Many risk factors have been associated with
TB, such as male gender [1], cigarette smoking [3,4], al-
cohol consumption [5], underweight [6], renal disease
[7], household contact [8], socioeconomic status [9], and
diabetes mellitus [10]. As diabetes patients increased
year by year, more and more studies focused on TB pre-
vention in diabetic group in these years [10-17].s is an Open Access article distributed under the terms of the Creative
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were recorded in 2012, including 8,546 males and 3,674
females [18]. Among these cases, about 52% were aged
over 65 years, with the disease possibly induced from
impaired immunity with aging. Furthermore, the ratio of
extra-pulmonary tuberculosis in Taiwan is decreasing
year by year, claiming only about 4% of all incidence tu-
berculosis in 2010 [19]. Hence, given that they are at
high risk for tuberculosis infection, especially pulmonary
tuberculosis, it is important for the elderly to be
screened. As an aging country composed of more than
11% of the population over 65 years, Taiwan has a high
prevalence of diabetes. According to the Nutrition and
Health Survey in Taiwan (NAHSIT) 2004–2008 [20], the
prevalence of diabetes in Taiwan was 8.8%, higher than
the global data of 8.3% [2]. The prevalence was especially
high in old people over 65 years, accounting for 27.7%
in males and 24% in females, which further increases the
risk of tuberculosis infection.
For tuberculosis prevention, many studies focus on the
effects of diabetes on tuberculosis infection. The risk of
tuberculosis infection not only rises in diabetes patients,
but is also associated with a higher risk of an increased
number of diabetes complications [10]. Diabetes patients
also require longer treatment and are more likely to de-
velop multi-drug resistant tuberculosis [21]. Addition-
ally, joint management of both diseases appears to
improve clinical outcomes [17]. However, most studies
to date have employed case control or cohort design. In
this study, we focus on the active screening of tubercu-
losis in elderly diabetes patients and assess other pos-
sible risk factors among this group of patients.
Methods
Study population
This single-center, cross-sectional study was supported
by the Centers for Disease Control (CDC) in Taiwan and
launched at Chiayi Chang Gung Memorial Hospital
(CGMH), which has 1,339 beds and 4 endocrinologists.
The selection of study area (Chiayi County) is based on
the high proportion of people over 65 years. It reached
16.04% among all administrative districts in Taiwan in
2012 [22]. Meetings were held for the doctors of the
hospital and the nurses at the local public health centers
who were involved in this study to standardize the
screening process before the project.
From 2012 September 1st to November 25th, patients
with type 2 diabetes mellitus over the age of 65 years
were collected from inpatient and outpatient depart-
ments of the hospital and 14 of the 16 Public Health
Centers of Chiayi county (the other 2 centers had no
mobile screening vehicles). Public health nurses were al-
located to the mobile units equipped with X-ray ma-
chine to actively screen pulmonary TB in diabetic eldersin the communities. The study was approved by Chang
Gung Medical Foundation Institutional Review Board
(No. 101-2656B). Written informed consent was ob-
tained from each participant.
Data collection
All patients from the hospital and community received
screening included a questionnaire, laboratory test, and
chest X-ray. The questionnaire was designed to gather
basic medical information included age, gender, educa-
tion, body weight (BW), body height, body mass index
(BMI), waist circumference, smoking, alcohol drinking,
exercise habit, past history, family history of tubercu-
losis, and diabetes duration. Symptom selection was
based on a 7-point screening method [23], suggested by
the WHO and Taiwan CDC, including cough for 2 weeks
(score = 2), sputum (score = 2), chest pain (score = 1),
poor appetite (score = 1), and subjective body weight
loss (score = 1); a total score of 5 or more is suggestive
of tuberculosis. The reliability of this method was ana-
lyzed in all screening-confirmed tuberculosis patients.
Laboratory data included serum fasting sugar, lipid pro-
files, glycated hemoglobin (HbA1c), renal function, liver
function, and urine protein were measured in all patients
within 3 months of enrolled date. Chest radiographs
within 6 months were also obtained; for hospital cases,
they were read by a random radiologist; and for commu-
nity cases, the X-rays were sent to the Chest Hospital, De-
partment of Health and evaluated by the pulmonologists.
Confirmation of pulmonary tuberculosis
If tuberculosis was suspected after the screening, the hos-
pital cases were referred to the pulmonary or infectious
disease outpatient clinics of CGMH and community cases
were referred to the Chronic Disease Center for further
evaluation, diagnosis and treatment. Sputum samples
were collected from all suspicious cases, one sample
per day for three successive days. The samples were
sent for acid fast satin and mycobacterial culture, using
BACTEC MGIT 960 system and Löwenstein-Jensen
solid media simultaneously [24,25]. Sputum acid fast
stain positive was defined as screening positive and
sputum culture with Mycobacteria tuberculosis were
confirmed cases.
Statistical analysis
Descriptive statistics are expressed as mean ± SD. All of
the continuous variables were detected when the variables
followed normal distribution using the Kolmogorov-
Smirnov test. Homogeneity of variance was tested with
the Levene’s test. Student’s t-test applied to evaluate differ-
ences in mean values of normally distributed data. Cat-
egorical variables were tested using the Chi-square (χ2)
test or Fisher’s exact test. Univariate logistic regression
Table 1 Demographic characteristics (n = 3087)
Variables Mean ± SD n (%)
General data











≥10 years 1573 (51.0)
<10 years 1481 (48.0)
missing 33 (1.1)
Fasting sugar (mg/dL) 146.18 ± 51.79
HbA1c (%) 7.47 ± 1.44
HDL (mg/dL) 45.37 ± 12.14
LDL (mg/dL) 96.84 ± 29.23
TG (mg/dL) 137.17 ± 89.56
Creatinine (mg/dL) 1.49 ± 1.56
ALT (U/L) 29.47 ± 29.20
Data are n (%) unless indicated.
Abbreviation: BMI: body mass index; DM: diabetes mellitus; HbA1c: glycated
hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG:
triglyceride, ALT: alanine aminotransferase.
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factors associated with pulmonary TB. To control for po-
tential confounders, a multiple logistic regression model
with forward selection was used. The entry probability
was p = 0.1 or less and the removal probability was p> 0.2.
All statistical tests were two-tailed, and the significance
level was set at p = 0.05 or less. Model fit was assessed
using the Hosmer-Lemeshow goodness of fit test. Data




A total of 3,087 (2,141 hospital and 946 community)
type 2 diabetes patients over 65 years participated this
screening program. The participants without any missing
information were 2,979 individuals. The average age of
the participants was 74.15 ± 5.90 years old and 62.9% of
them were either overweight (BMI 24–27 kg/m2) or
obese (BMI ≥ 27 kg/m2), according to definitions by the
Taiwan Ministry of Health and Welfare [26]. About half
of the patients had diabetes for longer than 10 years and
the average level of HbA1c was 7.47 ± 1.44% (Table 1).
Eleven cases were screening positive (acid fast stain
positive) and 7 of them were confirmed with pulmonary
tuberculosis (4 non-tuberculosis mycobacteria). Another
5 patients were being under anti-tuberculosis treatment
when participating screening program. The TB preva-
lence rate was 3.89‰ (12/3,087). We defined the cases
of screening-confirmed TB and under treatment TB as
new TB group (active TB). Another 61 patients had pul-
monary tuberculosis history and 2 cases were acciden-
tally confirmed lung cancers.
Univariate logistic regression analysis for determinants of
active pulmonary TB
The difference of clinical characteristics between new
TB cases and not-new TB cases are shown in Table 2.
Male gender and a history of smoking are statistically
significant risk factors of TB infection. Liver cirrhosis
was also found to have a higher prevalence in the new
TB group.
A summary of the 7-point symptom screening of all
cases is also listed in Table 2. No difference was found
for the total score and the ratio of scores above 5 points
between the new TB and the not-new TB groups. There
was also no statistically significant difference in all symp-
toms except subjective body weight loss (50% vs. 12.5%,
p = 0.001).
Multivariate logistic regression analysis for independent
determinants of active pulmonary TB
In multivariate analysis, we included male gender, smok-
ing, liver cirrhosis and body weight loss. Male gender,smoking and liver cirrhosis were the factors that reached
statistic significant in univariate analysis in Table 2. The
reason why we included body weight loss is that under-
weight has been shown to be independently associated
with tuberculosis [6]. The Hosmer and Lemeshow test
indicates a χ2 of 0.512 (p = 0.474), suggesting that the
data fit the final model quite well. After adjustment, sub-
jective BW loss (OR: 6.635 [95% CI: 2.096-21.007]),
smoking (OR: 3.981 [95% CI: 1.246-12.718]), and liver
cirrhosis (OR: 10.307 [95% CI: 2.108-50.395]) remained
strongly associated with pulmonary tuberculosis (Table 3).
The characteristics of all TB group vs. non TB group
To more clearly view the possible risk factors for TB in-
fection, the characteristics of all TB cases (include new
TB and TB history cases) and non-TB cases are shown
in Table 4. More risk factors achieving statistical signifi-
cance included male gender, lower BMI, smoking, alco-
hol drinking, and TB family history. The diabetes
control status between the two groups was not signifi-
cantly different, except for TB patients having a higher
low-density lipoprotein (LDL). The prevalence of liver
Table 2 Clinical characteristics of the new TB group and control group
New TB Control p
value
OR (95% CI)








Male 10 (83.3) 1473 (47.9)
Female 2 (16.7) 1602 (52.1)




Yes 7 (58.3) 702 (22.8)




Yes 3 (25.0) 416 (13.5)




Fasting glucose (mg/dL) 166.35 ± 73.91 146.08 ± 51.67
HbA1c (%) 7.71 ± 1.56 7.46 ± 1.44 0.573 1.112 (0.769-1.608)
HDL (mg/dL) 41.00 ± 10.08 45.38 ± 12.15 0.378 0.966 (0.895-1.043)
LDL (mg/dL) 87.40 ± 20.23 96.86 ± 29.25 0.469 0.988 (0.956-1.021)
Triglyceride (mg/dL) 186.00 ± 143.61 137.02 ± 88.36 0.162 1.002 (0.999-1.006)
Creatinine (mg/dL) 1.39 ± 0.51 1.49 ± 1.56 0.824 0.951 (0.609-1.485)
ALT (U/L) 27.57 ± 12.84 29.48 ± 29.24 0.862 0.997 (0.965-1.030)





Yes 2 (16.7) 62 (2.0)




Yes 6 (50.0) 1975 (64.2)





Yes 1 (8.3) 185 (6.0)
No 11 (91.7) 2784 (90.5)
Cough≥ 2 wks (score =2)
0.146
0.218 (0.028-1.694)
Yes 1 (8.3) 872 (28.4)




Yes 4 (33.3) 737 (24.0)
No 8 (66.7) 2230 (72.5)
Chest pain (score =1)
0.994
0.992 (0.128-7.718)
Yes 1 (8.3) 249 (8.1)
No 11 (91.7) 2718 (88.4)
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Yes 2 (16.7) 362 (11.8)
No 10 (83.3) 2605 (84.7)
BW loss (score =1)
0.001**
6.997 (2.245-21.809)
Yes 6 (50.0) 371 (12.1)
No 6 (50.0) 2596 (84.4)
Data are n (%) unless indicated.
Abbreviation: BMI: body mass index; DM: diabetes mellitus; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT:
alanine aminotransferase.
New TB group: screening confirmed TB + under treatment TB.
Control group = all participants except new TB.
*p <0.05, **p < 0.01.
Lin et al. BMC Public Health 2015, 15:3 Page 5 of 8
http://www.biomedcentral.com/1471-2458/15/3cirrhosis was insignificant in all TB groups. However,
hypertension was less frequent in all patients with tuber-
culosis infection (41% vs. 64.7%, p< 0.001).Discussion
Although diabetes as an important risk factor of tubercu-
losis infection is well documented [10-13], most of the
relevant literature is retrospective. A systemic review in
2010 included only 12 studies about active screening for
TB in diabetic patients and some of them used non-
specific methods (such as chest X-ray) to diagnose TB
[15]. However, screening rate increased with the preva-
lence of TB in the study region and with the severity of
diabetes. One pilot large scale intensive screening project,
reported in China [14], enrolled 15,342 diabetes patients
over 14 years of age in 5 medical centers without docu-
mented HbA1c. Only symptom screening positive patients
went on for further studies for TB. From September 2011
to March 2012, the TB notification rate rose from 0.31-
1.11‰ (each medical center) to 3.52-7.74‰ (average of 5
centers for each quarter). In a similar symptom screening
project in a tertiary care hospital in south India, 38 of
7,083 diabetic patient already had TB and 12 of 125
underwent TB investigation were newly diagnosed TB.
The incidence rate increases with HbA1c level and dia-
betes duration, especially in patients with HbA1c over
9.0% and with diabetes duration over 10 years [16].Table 3 Multiple logistic regression model determining
independent risk factors for pulmonary tuberculosis
among 3,087 diabetes patients
Significant variables Adjust OR 95% CI p value
Smoking 3.981 1.246-12.718 0.020*
BW loss 6.635 2.096-21.007 0.001**
Liver cirrhosis 10.307 2.108-50.395 0.004**
Abbreviation: BW: body weight.
*p <0.05, **p < 0.01.Another symptom screening research in Mexico detected
38 TB cases in 7,763 diabetes patients and 11 of them
were unaware of their TB [17]. These studies pointed out
that active screening and better glucose control might be
important in TB prevention.
In Taiwan, there were 12,220 TB notifications in 2012
and 6,328 (52%) of them were over 65 years of age [18].
The prevalence of TB in the general population and in the
elderly over 65 years was 0.52‰ and 2.43‰ respectively.
In our main study area of Chiayi County, the data was
similar, 0.62‰ and 2.54‰, indicating an increased risk of
TB infection in the elderly. Similarly, Baker MA et al. re-
ported that diabetes and treated diabetes patients had an
increased risk for TB (Hazard Ratio: 3.60 & 4.37, respect-
ively) [10]. According to our findings, the prevalence rate
of TB (3.89‰) was further increased 6- to 7-fold in ad-
vanced aged diabetes patients, suggesting the worth of
wide-spread screening.
Two comorbidities reached statistical significance in our
study: higher liver cirrhosis prevalence in the new TB group
and lower hypertension prevalence rate in all TB groups.
Based on previous research in Taiwan, liver cirrhosis was
not found to be a risk factor of pulmonary TB with pul-
monary infection [27], but this finding may be due to an in-
sufficient number of active TB cases. Further subgroup
studies on the etiologies of liver cirrhosis are also needed to
clarify the relation between liver cirrhosis and active tuber-
culosis in diabetic older patients. Furthermore, BMI was
documented to have a positive relationship with blood
pressure [28], and being overweight was also associated
with high risk of hypertension and cardiovascular events
[29]; for these reasons, the lower BMI in all TB groups
likely resulted in a lower hypertension prevalence rate.
Other risk factors, such as male gender, lower BMI, smok-
ing, alcohol drinking, and TB family history are comparable
with previous findings [1,3-6,8,16].
Accumulating literatures have described the difference
in lipid profiles between TB and health controls, show-
ing lower levels of total cholesterol, LDL, and high-
Table 4 Clinical characteristics of the all TB group vs non TB group
All TB Non TB p value OR (95% CI)
(n = 73) (n = 3014)
General data




Male 56 (76.7) 1427 (47.3)
Female 17 (23.3) 1587 (52.7)




Yes 31 (42.5) 678 (22.5)




Yes 20 (27.4) 399 (13.2)




Yes 6 (8.2) 45 (1.5)
No 67 (91.8) 2969 (98.5)
DM status
Fasting glucose (mg/dL) 147.15 ± 58.64 146.15 ± 51.62 0.881 1.000 (0.996-1.005)
HbA1c (%) 7.57 ± 1.61 7.46 ± 1.43 0.541 1.050 (0.899-1.226)
HDL (mg/dL) 41.99 ± 11.79 45.44 ± 12.14 0.062 0.974 (0.948-1.001)
LDL (mg/dL) 107.64 ± 35.20 96.60 ± 29.05 0.006* 1.012 (1.003-1.020)
Triglyceride (mg/dL) 138.98 ± 75.20 137.13 ± 89.86 0.886 1.000 (0.997-1.003)
Creatinine (mg/dL) 1.64 ± 1.80 1.49 ± 1.56 0.446 1.054 (0.921-1.206)
ALT (U/L) 27.20 ± 17.82 29.52 ± 29.39 0.615 0.996 (0.982-1.011)
DM duration (year) 10.16 ± 7.37 10.63 ± 7.59 0.606 0.992 (0.960-1.024)
Comorbidities
Liver cirrhosis
0.668Yes 2 (2.7) 62 (2.1) 1.340 (0.321-5.585)




Yes 32 (43.8) 1949 (64.7)
No 41 (56.2) 1062 (35.2)
Data are n (%) unless indicated.
Abbreviation: BMI: body mass index; DM: diabetes mellitus; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT:
alanine aminotransferase.
All TB group: New TB group + patients with TB history.
Non TB group: all participants except all TB group.
*p <0.05, **p < 0.01, ***p < 0.001.
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Some authors speculated that it might be the result of
increased lipid metabolism during inflammatory or in-
fection status for immune response [32]. In our study,
however, the levels of LDL and HDL tended to be lower
in the new TB group without statistical significance. The
reasons for this discrepancy are not clear and may be at-
tributed to the insufficient numbers of TB cases and dif-
ferent patient population in this study.Based on a survey of symptoms in 313 adult tubercu-
losis patients, the percentage of cough ≥ 2 weeks, chest
pain, anorexia, and body weight loss was reported as
only 48.2%, 41.0%, 40.6%, and 44.5%, respectively [33].
In the elderly, one meta-analysis review reported no dif-
ferences between old and young TB patients with re-
spect to cough, sputum production, weight loss, and
fatigue, but older patients had a lower prevalence of
fever, sweating, and hemoptysis [34]. In this study, we
Lin et al. BMC Public Health 2015, 15:3 Page 7 of 8
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points nor any symptom could clearly distinguish TB
cases, with the exception of subjective body weight loss.
Similarly, the weakness of symptom screening was also
demonstrated in a Vietnam study [35]. In fact, we
showed that subjective body weight loss is an independ-
ent factor associated with pulmonary TB. In this regard,
underweight has been shown to be an independent fac-
tor associated with tuberculosis [6]. Taken together, eld-
erly diabetic patients with complaints of body weight
loss should prompt active TB screening in practice.
This study has several limitations. The first limitation
is about the short duration. In an observational study in
the U.S., TB was observed to be a seasonal disease, with
a peak in spring and trough in late fall [36]. Our study
period that covered September to November, the results
may thus underestimate of the effect of intensive screen-
ing due to relatively lower incidence rate. Secondly, we
examined acid fast stain and mycobacterial culture only
in suspicious cases. It is likely that we underestimated
the occurrence of pulmonary TB in this population. This
underestimation may constitute an under-reporting bias
and negatively impact the accuracy of the risk factors for
TB in this analysis. Further studies are needed to clarify
this issue.
Conclusion
Subjective body weight loss, smoking and liver cirrhosis
are independent factors associated with pulmonary tu-
berculosis in elderly diabetic patients. In these subgroups
of patients, active surveillance should be prompted to
identify patients who are in need of treatment. Consider-
ing the potential benefit of joint management of TB and
DM, further investigations are needed to study the im-
pact of active screening program on the treatment out-
comes in elderly diabetic patients with TB.
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